TSLP and Alzheimer disease: In line with this theory, combined treatment with a PAR2 inhibitor and a lactobionic acid (LBA) (‘super acid’) exhibited therapeutic effects on hapten-induced atopic dermatitis (AD)-like dermatitis in a murine model in which elevations of epidermal TSLP paralleled development of the dermatitis (5).